Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
This week, Im going to focus on a simple dividend strategy that has produced some amazing results over the last few years.
This strategy is both easy to build and easy to use with the Research Wizard.
The parameters to this screen are as follows:
- Price >= $10
- Market Cap >= $500 mil.
- Zacks Rank
- Current Dividend Yield >= 8%
The Results:I ran a series of tests using a 24-week holding period over the last six-and-a-half years.
This strategy also performed great using a 12-week holding period.
A four-week holding period showed excellent results as well, but rebalancing your portfolio every four weeks would likely preclude you from receiving many of the dividends that these stocks produce.
Either way though, this Dividend Strategy has been a consistent performer through the ups and downs of the market over the last six-and-a-half years. (And hopefully in the years to come.)
Here are three stocks from this weeks list (for 12/4/07):
( BPT ) BP Prudhoe Bay Royalty Trust
GKK Gramercy Capital Corp.
MTA Magyar Telekom Nyrt
To find other stocks that qualify for this winning strategy, sign up for your free trial to the Research Wizard. Test this screen and others or build your own strategies and test them.
Remember the key to successful screening is in discovering those screens that have produced profitable results in the past. And thats exactly what you get with the powerful Backtesting ability of Research Wizard. Click here to find out more about our free trial
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Read the full on MYTAY
Read the full on GPT
Read the full on BPT